Update 2008, Q3 Live!

₄₆Patrick W Serruys

This is an abridged 2007 data mining report for Patrick W Serruys. The complete report is available only to the community members. As a guest user you can access the free unabridged reports for this author for the years prior to 2004: 2002, 2003.

Authoratory community membership is free for a member of educational or government organization. If you are already a community member please login or create FREE account to start using Authoratory now!

Key Opinion Leader In [Patrick W Serruys is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

₁Immunosuppressive Agents | ₁Drug Delivery Systems | ₂Coronary Restenosis | ₂Stents | ₂Coronary Thrombosis | ₂Sirolimus | ₂Paclitaxel | ₃Coronary Disease | ₄Coronary Artery Disease | ₅Ultrasonography, Interventional | ₆Angioplasty, Transluminal, Percutaneous Coronary | ₉Coronary Stenosis | ₁₁Coronary Angiography | ₁₃Follow-Up Studies | ₂₃Myocardial Infarction | ₂₇Treatment Outcome | ₃₄Coronary Vessels | ₄₂Clinical Trials as Topic | ₄₉Predictive Value of Tests | ₅₄Randomized Controlled Trials as Topic | ₆₁Atherosclerosis | ₈₀Survival Analysis | ₈₈Middle Aged | ₁₀₂Male | ₁₀₃Prospective Studies | ₁₀₃Registries | ₁₃₄Aged | ₁₃₈Humans | ₂₁₅Female | ₂₄₉Time Factors | ₅₁₂Retrospective Studies

Keywords (32) [keywords assigned to Patrick W Serruys articles by PubMed, the leading number and the color conveys importance]

hidden, requires login

Other [context-specific ads]

Patrick W Serruys Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; Patrick W Serruys might be a good expert witness on these terms]

hidden, requires login

Authoratory™
•home •community •tutorial •authors •keywords •search •top ranked •login	Update 2008, Q3 Live! Excel CSV XML print ₄₆Patrick W Serruys << 2006 \| 2007 \| 2008 Summary Social Network Interests Funding Articles Comments All This is an abridged 2007 data mining report for Patrick W Serruys. The complete report is available only to the community members. As a guest user you can access the free unabridged reports for this author for the years prior to 2004: 2002, 2003. Authoratory community membership is free for a member of educational or government organization. If you are already a community member please login or create FREE account to start using Authoratory now! Key Opinion Leader In [Patrick W Serruys is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors] ₁Immunosuppressive Agents \| ₁Drug Delivery Systems \| ₂Coronary Restenosis \| ₂Stents \| ₂Coronary Thrombosis \| ₂Sirolimus \| ₂Paclitaxel \| ₃Coronary Disease \| ₄Coronary Artery Disease \| ₅Ultrasonography, Interventional \| ₆Angioplasty, Transluminal, Percutaneous Coronary \| ₉Coronary Stenosis \| ₁₁Coronary Angiography \| ₁₃Follow-Up Studies \| ₂₃Myocardial Infarction \| ₂₇Treatment Outcome \| ₃₄Coronary Vessels \| ₄₂Clinical Trials as Topic \| ₄₉Predictive Value of Tests \| ₅₄Randomized Controlled Trials as Topic \| ₆₁Atherosclerosis \| ₈₀Survival Analysis \| ₈₈Middle Aged \| ₁₀₂Male \| ₁₀₃Prospective Studies \| ₁₀₃Registries \| ₁₃₄Aged \| ₁₃₈Humans \| ₂₁₅Female \| ₂₄₉Time Factors \| ₅₁₂Retrospective Studies Keywords (32) [keywords assigned to Patrick W Serruys articles by PubMed, the leading number and the color conveys importance] hidden, requires login Other [context-specific ads] Patrick W Serruys Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; Patrick W Serruys might be a good expert witness on these terms] hidden, requires login

	Copyright © 2006-2008 Authoratory.com \| All rights reserved \| Terms of use \| Privacy policy The content of this page was generated automatically by a computer program.